Moderna Aces COVID-19 Vaccine Results With 94.5% Efficacy

Outperforms Pfizer At First Analysis

 
• By Andrew McConaghie
Moderna_Pills_Syringe
Moderna now looks set to join Pfizer/BioNTech in gaining emergency use authorization before the end of 2020.

More from Business

More from Scrip